Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells
Naunyn-Schmiedeberg s Archives of PharmacologyPublished 12 December 1997Open access
Karl‐Norbert Klotz, Jutta Hessling, Jutta Hegler, Ch. Owman, Björn Kull, Bertil B. Fredholm
Citations723
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacological characterization and are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.
Abstract
Although many beta1-receptor antagonists and beta2-receptor agonists have been used in pharmacotherapy for many years their pharmacological properties at all three known subtypes of beta-adrenergic receptors are not always well characterized. The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background. We generated Chinese hamster ovary (CHO) cells stably expressing the three beta-adrenergic receptor subtypes at comparable levels. We characterized these receptor subtypes and analyzed the affinity of routinely used drugs as well as experimental compounds in competition binding studies, using the non-selective antagonist 125I-cyanopindolol as a radioligand. Furthermore, we analyzed the beta-receptor-mediated adenylyl cyclase activity in isolated membranes from these cell lines. The results from our experiments show that all compounds exhibit distinct patterns of selectivity and activity at the three beta-receptor subtypes. In particular, a number of beta2- or beta3-receptor agonists that are inverse agonists at the other subtypes were identified. In addition, beta1-receptor antagonists with agonistic activity at beta2- and beta3-receptors were found. These specific mixtures of agonism, antagonism, and inverse agonism at different subtypes may have important implications for the therapeutic use of the respective compounds.
Keywords
NeuroscienceBiochemistry, Genetics and Molecular Biology
Analytical BiochemistryA Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
225,378 Citations1976Mark A. Bradford
Biochemical PharmacologyRelationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
12,904 Citations1973Yung-Chi Cheng, William H. Prusoff
The analysis described shows K I does not equal I 50 when competitive inhibition kinetics apply; however, K I is equal to I 50 under conditions of either noncompetitive or uncompetitive kinetics.
Molecular and Cellular BiologyHigh-efficiency transformation of mammalian cells by plasmid DNA.
5,334 Citations1987C Chen, Hiroto Okayama
A simple calcium phosphate transfection protocol and neo marker vectors that achieve highly efficient transformation of mammalian cells are described and linear DNA is almost inactive in mammalian cells.
Pharmacological ReviewsNomenclature and classification of purinoceptors.
1,585 Citations1994Bertil B. Fredholm, Maria P. Abbracchio +6 more
The evidence is now compelling that ATP plays important physiological and/ or pathophysiological roles in a variety of biological systems, and the presence of receptors for ADP and adenosine (presumably A2) receptors exist on platelets is compelling.
Journal of NeurochemistryADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS
1,372 Citations1979Dietrich van Calker, Margarete Müller +1 more
In cell cultures of glial character derived from perinatal mouse brain adenosine elicits two effects; at submicromolar concentrations it inhibits the increase in the intracellular level of cyclic AMP caused by β‐adrenoceptor agonists and at concentrations above micromolar it increases the level of CyclicAMP in the cultures.
ScienceMolecular Characterization of the Human β <sub>3</sub> -Adrenergic Receptor
1,081 Citations1989Laurent J. Emorine, Stéfano Marullo +5 more
Novel beta-AR agonists having high thermogenic, antiobesity, and antidiabetic activities in animal models are among the most potent stimulators of the beta 3-AR.
Proceedings of the National Academy of SciencesSubclasses of external adenosine receptors.
1,079 Citations1980Constantine Londos, Dermot M.F. Cooper +1 more
The potency of adenosine is intermediate between the potencies of these two analogs and is maintained in physiological responses in intact cells, such as steroidogenesis and inhibition of lipolysis.
Molecular PharmacologyCharacterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
832 Citations1986Robert F. Bruns, Gina H. Lu +1 more
The regional distribution of [3H]NECA binding and the affinities of adenosine agonists and antagonists for inhibition of binding indicate that the site labeled by [3NECA belongs to the high affinity, or A2a, subclass of A2 receptor.
Naunyn-Schmiedeberg s Archives of PharmacologyComparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells
723 Citations1997Karl‐Norbert Klotz, Jutta Hessling +5 more
The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacological characterization and are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.
Journal of Medicinal ChemistryAdenosine receptors: targets for future drugs
684 Citations1982John W. Daly
Pharmacological ReviewsVascular Adrenoceptors: An Update
682 Citations2001Serafim Guimarães, D. Moura
The increased knowledge on the involvement of vascular adrenoceptors in many diseases like Raynaud's, scleroderma, several neurological degenerative diseases (familial amyloidotic polyneuropathy, Parkinson disease, multiple-system atrophy), some kinds of hypertension, etc., will contribute to new and better therapeutic approaches.
Pharmacological ReviewsAdrenergic and Muscarinic Receptors in the Human Heart
666 Citations1999Otto‐Erich Brodde, Martin C. Michel
Cardiac function is controlled by the autonomic nervous system (i.e., the sympathetic and the parasympathetic nervous systems), which act via adrenoceptors and muscarinic acetylcholine receptors, respectively.
ScienceSelective Amplification And Cloning Of Four New Members Of The G Protein-coupled Receptor Family
641 Citations1989Frédérick Libert, Marc Parmentier +7 more
An approach based on the polymerase chain reaction has been devised to clone new members of the family of genes encoding guanosine triphosphate-binding protein (G protein)-coupled receptors, suggesting that they are members of a new subfamily of receptors with a very short nonglycosylated amino-terminal extension.
Proceedings of the National Academy of SciencesCloning of the cDNA for the human beta 1-adrenergic receptor.
580 Citations1987Thomas Frielle, Sheila Collins +4 more
RNA blot analysis indicates a message of 2.5 kilobases in rat tissues, with a pattern of tissue distribution consistent with beta 1AR binding, which suggests that the avian gene encoding beta AR and the human gene encodingbeta 1AR evolved from a common ancestral gene.
Journal of Clinical InvestigationTissue distribution of beta 3-adrenergic receptor mRNA in man.
531 Citations1993Stéphane Krief, Fredrik Lönnqvist +7 more
It is demonstrated that substantial amounts of brown adipocytes exist throughout life in adipose deposits, which are generally classified as white, and these deposits are the main sites of beta 3-AR expression, which also occurs in gallbladder and colon.
Proceedings of the National Academy of SciencesMolecular cloning and characterization of the human A3 adenosine receptor.
422 Citations1993Chris Salvatore, Marlene A. Jacobson +3 more
The human A3 adenosine receptor was cloned from a striatal cDNA library using a probe derived from the homologous rat sequence and Antagonist potencies determined by Schild analyses correlated well with those established by competition for radioligand binding.
Naunyn-Schmiedeberg s Archives of Pharmacology8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) ? a selective high affinity antagonist radioligand for A1 adenosine receptors
395 Citations1987Martin J. Lohse, Karl‐Norbert Klotz +4 more
The binding properties of 8-cyclopentyl-1,3-dipropylxanthine as an antagonist ligand for A1 adenosine receptors appeared superior to those of other agonist and antagonist radioligands for the A1 receptor.
Pharmacology & TherapeuticsBeta-adrenoceptors in cardiac disease
262 Citations1993Otto‐Erich Brodde
It appears that the best therapy for severe heart failure is a successful heart transplant, since in the transplanted heart beta-adrenoceptor number and function seems to be normalized, and the data currently available do not suggest any development of super- or subsensitivity of postsynaptic cardiac beta- adrenoceptors in the transplantanted human heart.
Analytical BiochemistryA modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid
258 Citations1990Christer Nordstedt, Bertil B. Fredholm
There was good agreement between cAMP values obtained with the protein-binding method and commercially available radioimmunoassays that were used as reference methods.
Journal of Medicinal ChemistryStructure-Activity Relationships of N6-Benzyladenosine-5'-uronamides as A3-Selective Adenosine Agonists
238 Citations1994Carola Gallo‐Rodriguez, Xiao-duo Ji +7 more
5'-N-Methyluronamides and N6-(3-substituted-benzyl)adenosines are optimal for potency and selectivity at A3 receptors and a 4-methoxy group best favored A3 selectivity.
Molecular PharmacologyNegative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
238 Citations1994Philippe Samama, Gang Pei +3 more
It is shown that, of several beta-adrenergic receptor-blocking drugs tested, only two, ICI 118551 and betaxolol, inhibit the basal signaling activity of the beta 2-adRenergic receptor, thus acting as negative antagonists.
Journal of Biological ChemistryThe Myocardium-protective Gly-49 Variant of the β1-Adrenergic Receptor Exhibits Constitutive Activity and Increased Desensitization and Down-regulation
226 Citations2002Malin Levin, Stéfano Marullo +3 more
The Gly-49-β1AR displayed a more profound agonist-promoted down-regulation than the Ser-49 variant, further supporting the concept that β1AR desensitization is protective in heart failure.
Biochemical and Biophysical Research CommunicationsMolecular cloning and expression of an adenosine A2b receptor from human brain
200 Citations1992Kerrie D. Pierce, Timothy J. Furlong +2 more
A novel receptor cDNA was isolated from a human hippocampal cDNA library and it is proposed that the novel receptor is a human brain adenosine A2b receptor subtype.
Molecular PharmacologyA binding site model and structure-activity relationships for the rat A3 adenosine receptor.
178 Citations1994P J van Galen, Anna Bergen +6 more
The model presented here, which is consistent with the detailed SAR found in this study, may serve to suggest future chemical modification, site-directed mutagenesis, and SAR studies to further define essential characteristics of the ligand-receptor interaction and to develop even more potent and selective A3 receptor ligands.
European Journal of Pharmacologyβ-Adrenoceptor agonists and asthma—100 years of development
177 Citations2002Bertil Waldeck
Throughout the 20th century, beta-adrenoceptor agonists have been developed and marketed as racemates and there is so far no compelling evidence that the presence of the less active (S)-enantiomer is of any harm to the patient.
Naunyn-Schmiedeberg s Archives of PharmacologyThe affinity of (?)-propranolol for ? 1- and ? 1-autoreceptors of human heart
177 Citations1985Esther Gille, Horst Lemoine +2 more
It is concluded that the concentration of physiological catecholamines at the human heart beta-adrenoceptors is limited by neuronal capture but not by extraneuronal uptake.
PubMedReduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
168 Citations1977Jakobs Kh, Wilhelm Saur +1 more
The effects of the alpha- and beta-adrenergic components of epinephrine on adenylate cyclase activity were studied in lyastes of human platelets and appeared to be immediate and specific for platelets from species in which alpha- adrenergic stimulation caused aggregation.
Naunyn-Schmiedeberg s Archives of Pharmacology2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors
160 Citations1988Martin J. Lohse, Karl‐Norbert Klotz +4 more
CCPA is an agonist at A1 adenosine receptors with a 4-foldHigher selectivity and 2-fold higher affinity than CPA, and a considerably higher selectivity than the standard A1 receptor agonist R-N6-phenylisopropyladenosine (R-PIA).
Biochemical PharmacologyFunctional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts
139 Citations1994L. Ellen Brackett, John W. Daly
Structural-activity relationships suggested that the regions of interaction with 5'- and N6-substituents of ADO were similar for both the PC12 A2a and NIH 3T3 A2b receptor, however, ADO analogs with large substituents in the 2'-position, such as 2-cyclohexylethoxy ADO and CGS 21680, were highly selective for the A 2a receptor.
Molecular PharmacologyStructural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
132 Citations1993Nathalie Blin, Luc Camoin +2 more
Structural-activity relationship analysis indicates that potent or selective beta 3-AR compounds, in addition to possessing a pharmacophore common to all beta-AR ligands, contain a long and bulky alkylamine substituent moiety, which is able to adopt and exchange extended and stacked conformations.
Naunyn-Schmiedeberg s Archives of Pharmacology2-Chloro-N6-[3H]cyclopentyladenosine ([3HCCPA) ?a high affinity agonist radioligand for A1 adenosine receptors
128 Citations1989Karl‐Norbert Klotz, Martin J. Lohse +4 more
Based on the subnanomolar affinity and the high selectivity for A1 receptors [3H]CCPA proved to be a useful agonist radioligand for characterization of A1 adenosine receptors also in tissues with very low receptor density.
Drugs of the FutureA3-adenosine receptors: Design of selective ligands and therapeutic prospects
125 Citations1995Kenneth A. Jacobson, Hea O Kim +4 more
There is a tremendous potential for development for therapeutic purposes of selective drugs, either agonists or antagonists, acting at this receptor, through cloning and the synthesis of selective agonists.
PubMedPotent and selective human beta(3)-adrenergic receptor antagonists.
125 Citations1999Mari R. Candelore, Liping Deng +7 more
Novel and selective beta(3)-AR antagonists with high affinity for the human receptor are described and specific 3'-phenoxy substitutions are described that transform these compounds from potent agonists into selective antagonists.
Biochemical and Biophysical Research CommunicationsCloning and functional characterization of a human Al adenosine receptor
120 Citations1992Frédérick Libert, Jacqueline Van Sande +6 more
A human brain hippocampus cDNA library was screened by hybridization with a dog A1 adenosine receptor cDNA probe and individual clones of stably transfected CHO cells expressing the human A1 receptor were obtained and tested for their response to the A1 agonist CPA [N6-cyclopentyladenosine] in the presence of forskolin.
European Journal of BiochemistryExpression of three human β‐adrenergic‐receptor subtypes in transfected chinese hamster ovary cells
119 Citations1991K. Tate, Marie‐M. BRIEND‐SUTREN +4 more
It is likely that the pattern of ligand binding and adenylate cyclase activation, mediated by the new beta 3 AR in CHO cells, also reflects the yet-undetermined pharmacological profile in humans.
Molecular Brain ResearchA cDNA encoding the precursor of the rat neuropeptide, neurokinin B
113 Citations1987Tom I. Bonner, Hans‐Urs Affolter +2 more
In situ hybridization histochemistry indicates that the message is widely distributed in the rat brain in a pattern distinct from that of substance P message.
Molecular PharmacologyDifferential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
113 Citations1994Brenda S. Whaley, N. Yuan +3 more
A method is introduced that allows calculation of beta AR coupling efficiency while taking into account the effect of variable receptor levels, and provides a quantitative means for the determination of coupling efficiency of the receptor/G protein/adenylyl cyclase system over wide variations in receptor levels.
Annual Review of PhysiologyMolecular Mechanisms of Beta-Adrenergic Relaxation of Airway Smooth Muscle
110 Citations1996Michael I. Kotlikoff, Kristine E. Kamm
This review summarizes recent data on the two specific mechanisms of beta-adrenergic relaxation of airway smooth muscle: beta 2- adrenergic receptor stimulation results in the opening of large-conductance, calcium-activated potassium channels, and an attendant hyperpolarization of the myocyte.
Molecular PharmacologyFunctional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells.
103 Citations1992Stephen B. Liggett
Although the human and rat receptors exhibited similar properties with respect to catecholamine agonists, numerous differences in the potency and efficacy of synthetic noncatecholamines agonists were noted, indicating that the action of atypical agonists at rodent beta 3AR may not be predictive of therapeutic potential in humans.
Journal of Biological ChemistryPhotoaffinity labeling of A1-adenosine receptors.
96 Citations1985Karl‐Norbert Klotz, G. Cristalli +3 more
The results indicate that 125I-AHPIA identifies the ligand-binding subunit of the A1-adenosine receptor, which is a peptide with Mr = 35,000, which can be blocked specifically and stereoselectively by adenosine receptors agonists and antagonists in a manner which is typical for the A 1-subtype.
Journal of Pharmacology and Experimental TherapeuticsQuantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
94 Citations1986Kim A. Neve, Paul McGonigle +1 more
A method of simultaneous regression analysis of multiple inhibition curves, using the program MLAB on the PROPHET system, was used to quantify the selectivity of radioligands for beta-1 or beta-2 adrenergic receptors.
Journal of Biological Chemistryβ3-Adrenergic Receptors Regulate Retinal Endothelial Cell Migration and Proliferation
91 Citations2003Jena J. Steinle, George W. Booz +3 more
The hypothesis that beta3-adrenergic receptors play a role in proliferation and migration of cultured human retinal endothelial cells is supported.
Bioorganic & Medicinal Chemistrysynthesis of new Δ2-isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonists
86 Citations1998Paola Conti, Clelia Dallanoce +3 more
A series of delta 2-isoxazoline derivatives structurally related to Broxaterol 1 and Falintolol 3 has been prepared and evaluated for their binding affinity to beta 1- and beta 2-adrenergic receptors.
Molecular PharmacologyExpression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
81 Citations1988Michel Bouvier, Mark Hnatowich +5 more
The data indicate that the expressed human beta 2-AR displays typical functional characteristics of adenylate cyclase-coupled receptors including agonist-induced desensitization, and the availability of this series of cellular clones provides a unique set of biological reagents for future studies of beta2-AR function and regulation.
Naunyn-Schmiedeberg s Archives of PharmacologySeparation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration
70 Citations1988Martin J. Lohse, Bernice S. Elger +3 more
It is suggested that a solubilized A2 receptor-GS protein complex of human platelets can be separated from other [3H]NECA binding sites by gel filtration, which allows reliable radioligand binding studies of the A2 adenosine receptor of human Platelets.
Naunyn-Schmiedeberg s Archives of PharmacologyA1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C
64 Citations1994S. Freund, Martin Ungerer +1 more
Results indicate that a single A1 adenosine receptor can couple to two effector pathways, and that both effectors are activated via pertussis toxin sensitive G proteins.
British Journal of PharmacologyCharacterization of human A<sub>2A</sub> adenosine receptors with the antagonist radioligand [<sup>3</sup>H]‐SCH 58261
63 Citations1997Silvio Dionisotti, Ennio Ongini +4 more
The new antagonist radioligand is preferable to the receptor agonist radiolIGand [3H]‐CGS 21680 hitherto used to examine the pharmacology of human cloned A2A adenosine receptors.
Naunyn-Schmiedeberg s Archives of PharmacologyComparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling
61 Citations1991Karl‐Norbert Klotz, Heidrun Vogt +1 more
The difference from the “classical” A1 receptor profile (R-PIA > -NECA > S- PIA) is not sufficient to speculate that A1 receptors subtypes may exist that are coupled to different effector systems.
British Journal of PharmacologyCharacterization of the human brain putative A<sub>2B</sub> adenosine receptor expressed in Chinese hamster ovary (CHO.A<sub>2B4</sub>) cells
52 Citations1996S P H Alexander, Jacqui Cooper +2 more
It is concluded that the A2B adenosine receptor cloned from human brain expressed in Chinese hamster ovary cells exhibits an identical pharmacological profile to native A 2B receptors in guinea‐pig brain.
FEBS LettersConstitutively active mutants of the β1‐adrenergic receptor
49 Citations1999Anne Laure Lattion, Liliane Abuin +2 more
The first evidence that point mutations can constitutively activate the beta(1)-adrenergic receptor (AR) is provided, and various levels of constitutive activity which could be partially inhibited by some beta-blockers are displayed.
Naunyn-Schmiedeberg s Archives of PharmacologyStable overexpression of human ?2-adrenergic receptors in mammalian cells
41 Citations1992Martin J. Lohse
The expression system described here allows the preparation of human beta 2-adrenergic receptors in quantities sufficient for pharmacological and biochemical investigations.
HeartEssential hypertension: the heart and hypertension
35 Citations2001K E Berkin, S G Ball
The impact of hypertension on the heart is much more important than its effect in causing stroke and renal failure in terms of numbers of patients affected and there is still undue emphasis on diastolic pressure, with little attention paid to isolated systolic pressure.
Nucleic Acids ResearchPrimary structure of the human beta-adrenergic receptor gene
30 Citations1987Peter R. Schofield, Lucy Rhee +1 more
British Journal of PharmacologyMutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the β<sub>2</sub>‐adrenergic receptor
26 Citations2002Renata Del Carmine, Caterina Ambrosio +4 more
The data demonstrate that there is an overall linkage between the configuration of the binding pocket and the intrinsic equilibrium between active and inactive receptor forms and that the strength of bonds between catechol ring and helix 5 is critically dependent on the rest of interactions of theβ‐ethanolamine tail with other residues of the β2‐AR binding pocket.
Proceedings of the National Academy of SciencesRecombinant hydrophilic region of murine retroviral protein p15E inhibits stimulated T-lymphocyte proliferation.
24 Citations1987D. Schmidt, Navneet Sidhu +2 more
Data provide direct evidence that a retroviral envelope protein can itself inhibit lymphoproliferative function and map the inhibitory activity to a specific region of p15E.
Current Opinion in PharmacologyBeta-blockers in chronic heart failure: What have we learned? What do we still need to know?
7 Citations2003Henry Krum
The impact of genetic polymorphisms on the response to beta-blocker therapy, as well as interaction of these agents with future heart failure therapies, requires extensive investigation.